Nonfasting Lipids OK for Initial Testing; Labs Urged to Use ‘Desirable’ Cut-Offs to Flag Results
...
Utility of Post Op Lab Testing Questioned for Some Gynecologic Patients
...
Low Histopathologic Agreement for DCIS, Atypia Breast Cancer
...
Molecular Profiling of Lung Cancer Tumors Feasible on National Scale
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
Viewpoints Debate Merits of Universal Tumor Sequencing
From - Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…